Back
Jasper Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
33
JSPR
Jasper Therapeutics
Last Price:
20.68
Seasonality Move:
102.65%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JSPR is experiencing selling pressure, which indicates risk of future bearish movement.
Jasper Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.3 | Sell |
| 20-day SMA: | 22.09 | Sell |
| 50-day SMA: | 20.77 | Sell |
| 200-day SMA: | 22.05 | Sell |
| 8-day EMA: | 22.05 | Sell |
| 20-day EMA: | 22.16 | Sell |
| 50-day EMA: | 21.47 | Sell |
| 200-day EMA: | 20.03 | Buy |
Jasper Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 41.66 | Sell |
| Chaikin Money Flow: | -121093 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.2 - 23.64) | Sell |
| Bollinger Bands (100): | (17.65 - 22.55) | Buy |
Jasper Therapeutics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Jasper Therapeutics Stock
Is Jasper Therapeutics Stock a Buy?
- Jasper Therapeutics share price is 20.47 while JSPR 8-day simple moving average is 22.30, which is a Sell signal.
- The stock price of JSPR is 20.47 while Jasper Therapeutics 20-day SMA is 22.09, which makes it a Sell.
- Jasper Therapeutics 50-day simple moving average is 20.77 while JSPR share price is 20.47, making it a Sell technically.
- JSPR stock price is 20.47 and Jasper Therapeutics 200-day simple moving average is 22.05, creating a Sell signal.
JSPR Technical Analysis vs Fundamental Analysis
Sell
33
Jasper Therapeutics (JSPR)
is a Sell
Is Jasper Therapeutics a Buy or a Sell?
-
Jasper Therapeutics stock is rated a Sell
The current Jasper Therapeutics [JSPR] share price is $20.47. The Score for JSPR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Jasper Therapeutics Stock Info
Market Cap:
307.08M
Price in USD:
20.47
Share Volume:
155.88K
Jasper Therapeutics 52-Week Range
52-Week High:
31.01
52-Week Low:
4.24
Sell
33
Jasper Therapeutics (JSPR)
is a Sell
Jasper Therapeutics Share Price Forecast
-
What is the Jasper Therapeutics stock price today?
The Jasper Therapeutics stock price is 20.47 USD today. -
Will JSPR stock go up or go down?
Jasper Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Jasper Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Jasper Therapeutics is overvalued.
Is Jasper Therapeutics Stock a Buy?
- Jasper Therapeutics share price is 20.47 while JSPR 8-day exponential moving average is 22.05, which is a Sell signal.
- The stock price of JSPR is 20.47 while Jasper Therapeutics 20-day EMA is 22.16, which makes it a Sell.
- Jasper Therapeutics 50-day exponential moving average is 21.47 while JSPR share price is 20.47, making it a Sell technically.
- JSPR stock price is 20.47 and Jasper Therapeutics 200-day simple moving average is 20.03, creating a Buy signal.
Fundamental Analysis of Jasper Therapeutics
Is Jasper Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Jasper Therapeutics
Should I short Jasper Therapeutics stock?
- JSPR Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Jasper Therapeutics is a Buy
- Jasper Therapeutics Relative Strength Index (RSI) is 41.66, which suggest Jasper Therapeutics is oversold
- The Bollinger Bands (25) for Jasper Therapeutics is (21.2 - 23.64), which suggest Jasper Therapeutics is a Buy
- The Bollinger Bands (100) for Jasper Therapeutics is (17.65 - 22.55), which suggest Jasper Therapeutics is a Buy
* Jasper Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.